Mineralys Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MLYS)

CUSIP: 603170101

Q1 2025 13F Holders as of 31 Mar 2025

Holder snapshot 7 signals
Share change
+14,635,297
Put/Call ratio
123%
SEC-reported price per share
$15.88
Number of holders
148
Value change
+$245,430,113
Number of buys
105
Open additional details 1 more signal available
Number of sells
39
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
79,235,030

Security key

603170101

Report period

Q1 2025

Institutions

148

Top holders

10

Ownership snapshot

Top reported holders of MLYS - Mineralys Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
ADAMS STREET PARTNERS LLC
Disclosed value leader
Catalys Pacific, LLC
Comparable rows
15/15
Latest evidence
31 Dec 2024
13D/G 13F Lead comparable stake: 2.3% 13D/G row: ADAMS STREET PARTNERS LLC Showing 1-6 of 15 holder rows.

Quick read

ADAMS STREET PARTNERS LLC leads the comparable SEC ownership view at 2.3%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ADAMS STREET PARTNERS LLC's linked filing trail.
Comparable ownership Top 5
ADAMS STREET PARTNERS LLC 2.3%
Catalys Pacific, LLC 11%
Samsara BioCapital, LLC 6.4%
RA CAPITAL MANAGEMENT, L.P. 6.1%
TCG Crossover Management, LLC 3.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
ADAMS STREET PARTNERS LLC
13D/G 13F
Company
2.3%
$15,320,183
1,129,807 shares
$0 31 Dec 2024
Catalys Pacific, LLC
13F
Company
13F
11%
$106,414,767
8,644,579 shares
31 Dec 2024
Samsara BioCapital, LLC
13F
Company
13F
6.4%
$62,472,216
5,074,916 shares
31 Dec 2024
RA CAPITAL MANAGEMENT, L.P.
13F
Company
13F
6.1%
$59,715,613
4,850,984 shares
31 Dec 2024
TCG Crossover Management, LLC
13F
Company
13F
3.1%
$30,408,962
2,470,265 shares
31 Dec 2024
BlackRock, Inc.
13F
Company
13F
2.7%
$26,325,207
2,138,522 shares
31 Dec 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
148
Shares
61,178,854
Rows available
148
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2025 vs Q1 2025 Across Filers

Q1 2025 holders
148
Q1 2025 holders
148
Holder diff
0
Investor Q1 2025 Shares Q1 2025 Shares Share Diff Share Chg % Q1 2025 value Q1 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .